SHINE Medical Technologies Stock 2005Funding to Date: $409.31MM

Founded in 2010 with a mission to deploy state-of-the-art fusion technology to solve global problems as a scalable path to practical fusion energy, SHINE Medical Technologies offers safe, clean, and affordable production of medical tracers and cancer treatment elements. SHINE envisions a transformed world in which nuclear fusion provides clean, abundant, and commercially viable power, while solving issues in the fields of industrial manufacturing, healthcare, and nuclear waste along the way.

Register for Details

For more details on financing and valuation for SHINE Medical Technologies, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for SHINE Medical Technologies.

Register Today


Management Team

Gregory Piefer Ph.D
Co-Founder & Chief Executive Officer
Todd Asmuth
President & Chief Strategy Officer
Chris Lee
Chief Financial Officer
Steve Miltenberger
Vice President of Special Projects & Chief Operating Officer
Ross Radel Ph.D
Chief Technology Officer
Don Zybak
Chief Accounting Officer
Eric Schutt
Chief of Staff & Vice President of Government Affairs

Board Members

Brett Chugg
Koch Disruptive Technologies
Gregory OD Smith
SHINE Medical Technologies
Paul Ryan
SHINE Medical Technologies

Other companies like SHINE Medical Technologies in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


SHINE Medical secures $50M in additional funding for radioisotope production facility in Janesville